New study demonstrates the efficacy of a promising celiac disease drug at the molecular level
A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase ...
Jun 24, 2024
0
51